1. Home
  2. KRRO vs CULP Comparison

KRRO vs CULP Comparison

Compare KRRO & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$11.65

Market Cap

58.6M

Sector

Health Care

ML Signal

HOLD

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$3.65

Market Cap

52.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRRO
CULP
Founded
2014
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Textiles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
58.6M
52.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRRO
CULP
Price
$11.65
$3.65
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$74.17
N/A
AVG Volume (30 Days)
221.9K
27.8K
Earning Date
03-17-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,371,000.00
$204,919,000.00
Revenue This Year
$145.49
N/A
Revenue Next Year
N/A
$6.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.20
$3.33
52 Week High
$55.89
$5.64

Technical Indicators

Market Signals
Indicator
KRRO
CULP
Relative Strength Index (RSI) 67.56 51.33
Support Level $9.88 $3.61
Resistance Level $10.93 $3.89
Average True Range (ATR) 0.86 0.17
MACD 0.48 0.02
Stochastic Oscillator 83.42 58.71

Price Performance

Historical Comparison
KRRO
CULP

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: